Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
NCT07763795
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 DiabetesSuperior UniversityActive Not RecruitingNot Applicable
NCT07763795Active Not Recruiting
Not Applicable
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and Q...Superior University
NCT07763860
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou DarghamRecruitingNot Applicable
NCT07763860Recruiting
Not Applicable
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou Dargham
NCT07764120
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, GrenobleNot Yet Recruiting
NCT07764120Not Yet Recruiting
—
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, Gren...
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07762898
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and FrailtyGansu University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07762898Not Yet Recruiting
Not Applicable
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and...Gansu University of Chine...
NCT07763704
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut UniversityNot Yet Recruiting
NCT07763704Not Yet Recruiting
—
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut University
NCT07763509
Calcium-Rich Food Versus Calcium Carbonate for Bone HealthCornell UniversityNot Yet RecruitingNot Applicable
NCT07763509Not Yet Recruiting
Not Applicable
Calcium-Rich Food Versus Calcium Carbonate for Bone HealthCornell University
NCT07762079
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion Program Among Patients With Mental Disorders - IRISFederation Regionale de Recherche en Psychiatrie et Sante Mentale OccitanieNot Yet RecruitingNot Applicable
NCT07762079Not Yet Recruiting
Not Applicable
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion P...Federation Regionale de R...
NCT07763600
Effect of Anesthesia Type on Surgeon Workload During Endoscopic Kidney Stone SurgeryMalatya Governor Research HospitalNot Yet Recruiting
NCT07763600Not Yet Recruiting
—
Effect of Anesthesia Type on Surgeon Workload During Endoscopic Kidney Stone Sur...Malatya Governor Research...
NCT07763184
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07763184Not Yet Recruiting
—
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Souther...
NCT07763665
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein ComplexAssiut UniversityNot Yet RecruitingPhase 4
NCT07763665Not Yet Recruiting
Phase 4
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Inju...Assiut University
NCT07763548
A Novel Two-Step Dosing Induction Strategy (The Propofol Challenge Test) to Minimize Propofol Injection PainErasme University HospitalNot Yet RecruitingPhase 4
NCT07763548Not Yet Recruiting
Phase 4
A Novel Two-Step Dosing Induction Strategy (The Propofol Challenge Test) to Mini...Erasme University Hospita...
NCT07763314
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022Cantonal Hospital of St. GallenCompleted
NCT07763314Completed
—
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Can...Cantonal Hospital of St....
NCT07761988
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society, Inc.Not Yet RecruitingNot Applicable
NCT07761988Not Yet Recruiting
Not Applicable
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society,...
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07763132
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blood Draws in ChildrenMarie LulkováRecruitingNot Applicable
NCT07763132Recruiting
Not Applicable
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blo...Marie Lulková
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified7 (35%)
Phase 12 (10%)
Phase 42 (10%)
Phase 21 (5%)